These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6594240)

  • 41. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.
    Bertram MA; Young LS
    Antimicrob Agents Chemother; 1984 Aug; 26(2):272-4. PubMed ID: 6435517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activity of imipenem against high inocula of Bacteroides species and Escherichia coli alone and in mixed culture.
    Ponte C; Soriano F; Santamaria M
    Eur J Clin Microbiol; 1984 Oct; 3(5):491-3. PubMed ID: 6389127
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
    Gimeno C; Cantón R; García A; Gobernado M;
    Rev Esp Quimioter; 2010 Sep; 23(3):144-52. PubMed ID: 20844845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of cross-resistance between imipenem and other beta-lactam antibiotics for Pseudomonas aeruginosa.
    Opferkuch W; Cullmann W
    Eur J Clin Microbiol; 1987 Jun; 6(3):330-2. PubMed ID: 3113943
    [No Abstract]   [Full Text] [Related]  

  • 46. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of the antimicrobial removal device, BACTEC 16B medium, and thiol broth in neutralizing antibacterial activities of imipenem, norfloxacin, and related agents.
    Weinberg E; Shungu DL; Gadebusch HH
    J Clin Microbiol; 1984 Feb; 19(2):207-9. PubMed ID: 6230369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In-vitro activity of Sch 34343 against anaerobic bacteria.
    Wexler H; Carter WT; Finegold SM
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():173-6. PubMed ID: 3861606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro effect of imipenem on Acinetobacter baumannii.
    Hostacká A
    Pharmazie; 1999 Jan; 54(1):70-2. PubMed ID: 9987801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
    Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
    Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to imipenem in Pseudomonas aeruginosa.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1995 Dec; 36(6):1037-41. PubMed ID: 8821603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In-vitro sensitivity of Bacteroidaceae, clostridia and propionibacteria to newer antimicrobial agents.
    Höffler U
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():41-6. PubMed ID: 3469196
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stability of doripenem, imipenem and meropenem at elevated room temperatures.
    Keel RA; Sutherland CA; Crandon JL; Nicolau DP
    Int J Antimicrob Agents; 2011 Feb; 37(2):184-5. PubMed ID: 20702066
    [No Abstract]   [Full Text] [Related]  

  • 54. [Bactericidal activity of biapenem against various bacteria].
    Hiraishi T; Miyata A; Hara T; Araake M; Ogawa H
    Jpn J Antibiot; 2001 Dec; 54(12):581-95. PubMed ID: 11877858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indirect Tris-EDTA Disk Testing Using Imipenem and Meropenem for Detection of OXA-48 Carbapenemase Production.
    Thomson GK; AbdelGhani S; Snyder JW; Thomson KS
    J Clin Microbiol; 2015 Nov; 53(11):3705-6. PubMed ID: 26292309
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbapenems: special properties contributing to their activity.
    Neu HC
    Am J Med; 1985 Jun; 78(6A):33-40. PubMed ID: 3873871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates.
    Ravizzola G; Pinsi G; Gonzales R; Colombrita D; Pirali F; Turano A
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1053-61. PubMed ID: 2620673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pharmacokinetics and antimicrobial activity of imipenem].
    Dette GA; Knothe H
    Infection; 1986; 14 Suppl 2():S113-21. PubMed ID: 3531025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.